Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Droplet microfluidics and split-GFP complementation enable selection of Chinese hamster ovary cells with high specific productivity of therapeutic glycoproteins
KTH, Skolan för bioteknologi (BIO), Proteomik och nanobioteknologi. (Johan Rockberg)ORCID-id: 0000-0003-1096-9061
KTH, Skolan för bioteknologi (BIO), Proteomik och nanobioteknologi.ORCID-id: 0000-0002-7875-2822
KTH, Centra, Science for Life Laboratory, SciLifeLab.
Visa övriga samt affilieringar
(Engelska)Manuskript (preprint) (Övrigt vetenskapligt)
Nationell ämneskategori
Läkemedelsbioteknik
Identifikatorer
URN: urn:nbn:se:kth:diva-212929OAI: oai:DiVA.org:kth-212929DiVA, id: diva2:1135903
Anmärkning

QC 20170828

Tillgänglig från: 2017-08-24 Skapad: 2017-08-24 Senast uppdaterad: 2020-01-10Bibliografiskt granskad
Ingår i avhandling
1. Cell line and protein engineering tools for production and characterization of biologics
Öppna denna publikation i ny flik eller fönster >>Cell line and protein engineering tools for production and characterization of biologics
2017 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Our increasing understanding of disease mechanisms coupled with technological advances has facilitated the generation of pharmaceutical proteins, which are able to address yet unmet medical needs. Diseases that were fatal in the past can now be treated with novel biological medications improving and prolonging life for many patients. Pharmaceutical protein production is, however, a complex undertaking, which is by no means problem-free. The demand for more complex proteins and the realization of the importance of post-translational modifications have led to an increasing use of mammalian cells for protein expression. Despite improvements in design and production, the costs required for the development of pharmaceutical proteins still are far greater than those for conventional, small molecule drugs. To render such treatments affordable for healthcare suppliers and assist in the implementation of precision medicine, further progress is needed. In five papers this thesis describes strategies and methods that can help to advance the development and manufacturing of pharmaceutical proteins. Two platforms for antibody engineering have been developed and evaluated, one of which allows for efficient screening of antibody libraries whilst the second enables the straightforward generation of bispecific antibodies. Moreover, a method for epitope mapping has been devised and applied to map the therapeutic antibody eculizumab’s epitope on its target protein. In a second step it was shown how this epitope information can be used to stratify patients and, thus, contribute to the realization of precision medicine. The fourth project focuses on the cell line development process during pharmaceutical protein production. A platform is described combining split-GFP and fluorescence-activated droplet sorting, which allows for the efficient selection of highly secreting cells from a heterogeneous cell pool. In an accompanying study, the split-GFP probe was improved to enable shorter assay times and increased sensitivity, desirable characteristics for high-throughput screening of cell pools. In summary, this thesis provides tools to improve design, development and production of future pharmaceutical proteins and as a result, it makes a contribution to the goal of implementing precision medicine through the generation of more cost-effective biopharmaceuticals for well-characterized patient groups.

Ort, förlag, år, upplaga, sidor
Stockholm: KTH Royal Institute of Technology, 2017. s. 91
Serie
TRITA-BIO-Report, ISSN 1654-2312 ; 2017:16
Nyckelord
Pharmaceutical proteins, precision medicine, antibody engineering, epitope mapping, cell line development, split-GFP
Nationell ämneskategori
Läkemedelsbioteknik
Forskningsämne
Bioteknologi
Identifikatorer
urn:nbn:se:kth:diva-212931 (URN)978-91-7729-497-9 (ISBN)
Disputation
2017-09-29, E3, Osquars backe 14, Stockholm, 10:00 (Engelska)
Opponent
Handledare
Anmärkning

QC 20170828

Tillgänglig från: 2017-08-28 Skapad: 2017-08-24 Senast uppdaterad: 2017-08-30Bibliografiskt granskad
2. Methods for cell line and protein engineering
Öppna denna publikation i ny flik eller fönster >>Methods for cell line and protein engineering
2018 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Therapeutic proteins are becoming increasingly important. They are desirable, as they typically possess low adverse effects and higher specificity compared to the traditional, small molecule drugs. But they are also more complex and involve different intricate and expensive development and production processes. Through new technologies in protein and cell line development, more efficient and safer drugs can be readily available and at a lower cost. This thesis gives an overview of how protein therapeutics are developed and produced. It explores strategies to improve the efficacy and safety of protein drugs and how to improve production yields. In the present investigation, two papers present new methods for high-throughput cloning and site-directed mutagenesis using solid-phase immobilization of DNA fragments. These methods were designed to generate new drug candidates with swiftness and ease. Three papers show the development of a new cell line screening system that combines droplet microfluidics and the split-GFP reporter system. This combination allows for relative quantification of secreted recombinant proteins between individual cells and provides a tool for the selection of the best-producing clones for final production from a heterologous cell pool. The final paper explores the possibility to produce proteins at a higher cell density by examining how the metabolome and proteome of a perfusion bioreactor evolve as the cell density reaches exceptionally high levels. The consistent goal of all of these studies is to expedite the development and improve the production of therapeutic proteins, to assist the discovery of new drugs and to bring down production and development costs. Engineered proteins can be used to cure previously incurable diseases or give current medications a higher efficacy. Lower production and development costs can make the treatments available to more people.

Ort, förlag, år, upplaga, sidor
KTH Royal Institute of Technology, 2018
Serie
TRITA-CBH-FOU ; 2018:14
Nyckelord
Cell line development, therapeutic proteins, protein engineering, molecular cloning, mutagenesis, split-GFP
Nationell ämneskategori
Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci)
Forskningsämne
Bioteknologi
Identifikatorer
urn:nbn:se:kth:diva-227195 (URN)978-91-7729-757-4 (ISBN)
Disputation
2018-05-31, Kollegiesalen, Brinellvägen 8, Stockholm, 10:00 (Engelska)
Opponent
Handledare
Anmärkning

QC 20180507

Tillgänglig från: 2018-05-07 Skapad: 2018-05-04 Senast uppdaterad: 2020-01-10Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Personposter BETA

Volk, Anna-LuisaLundqvist, MagnusHammar, PetterBai, YunpengUhlén, MathiasJoensson, Haakan N.Rockberg, Johan

Sök vidare i DiVA

Av författaren/redaktören
Volk, Anna-LuisaLundqvist, MagnusHammar, PetterBai, YunpengUhlén, MathiasJoensson, Haakan N.Rockberg, Johan
Av organisationen
Proteomik och nanobioteknologiScience for Life Laboratory, SciLifeLab
Läkemedelsbioteknik

Sök vidare utanför DiVA

GoogleGoogle Scholar

urn-nbn

Altmetricpoäng

urn-nbn
Totalt: 543 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf